Antitrust Antitrust

Spanish radiopharmacy cartel detected thanks to in-house research, says CNMC boss

By Nicholas Hirst
  • 24 Feb 2021 11:09
  • 24 Feb 2021 11:15

A cartel between two Spanish pharmaceutical companies that were fined almost 6 million euros ($7.3 million) was uncovered by the national competition authority's in-house detection unit, according to the agency's boss.

The source of the case is noteworthy because competition authorities across Europe — faced with falling leniency requests from cartelists —

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Nicholas Hirst

Chief Correspondent

Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News